Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Telomeres protect chromosomal ends and shorten with age.
• Telomere length is implicated in various diseases, including cancers.
• Melanoma is a significant skin cancer with complex genetic underpinnings.

Purpose of the Study:

• To investigate the association between telomere length and melanoma risk.
• To explore the role of TERT promoter mutations in melanoma development and progression.
• To understand telomere homeostasis in melanoma.

Main Methods:

• Analysis of telomere length in 1469 melanoma patients and 1158 healthy controls.
• Mendelian randomization using telomere length-associated polymorphisms.
• Genotyping for germline and somatic TERT promoter mutations.

Main Results:

• A statistically significant association was found between increased telomere length and melanoma risk (P = 6 × 10⁻¹⁰).
• Mendelian randomization confirmed this association, with an odds ratio of 2.66.
• Telomere attrition was more rapid in melanoma cases than controls, and faster in tumors with TERT promoter mutations.
• Germline TERT promoter mutation carriers had longer telomeres and earlier onset melanoma.
• Somatic TERT promoter mutations were associated with shorter telomeres in primary tumors.

Conclusions:

• Increased telomere length is a risk factor for melanoma.
• TERT promoter mutations perturb telomere homeostasis and influence melanoma progression.
• Telomere length and its regulation are critical in melanoma pathogenesis.